Newman Dignan & Sheerar, Inc. Azur Rx Bio Pharma, Inc. Call Options Transaction History
Newman Dignan & Sheerar, Inc.
- $457 Million
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
About AzurRx BioPharma, Inc.
- Ticker AZRX
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,575,104
- Market Cap $271M